X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs MERCK LTD - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA MERCK LTD TORRENT PHARMA/
MERCK LTD
 
P/E (TTM) x 36.8 45.4 80.9% View Chart
P/BV x 6.5 6.6 98.0% View Chart
Dividend Yield % 0.8 0.5 154.1%  

Financials

 TORRENT PHARMA   MERCK LTD
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
MERCK LTD
Dec-17
TORRENT PHARMA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,5501,358 114.2%   
Low Rs1,144933 122.6%   
Sales per share (Unadj.) Rs354.7665.0 53.3%  
Earnings per share (Unadj.) Rs40.156.6 70.8%  
Cash flow per share (Unadj.) Rs64.272.5 88.6%  
Dividends per share (Unadj.) Rs14.0015.00 93.3%  
Dividend yield (eoy) %1.01.3 79.4%  
Book value per share (Unadj.) Rs273.1441.7 61.8%  
Shares outstanding (eoy) m169.2216.60 1,019.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.81.7 220.5%   
Avg P/E ratio x33.620.2 166.0%  
P/CF ratio (eoy) x21.015.8 132.7%  
Price / Book Value ratio x4.92.6 190.2%  
Dividend payout %34.926.5 131.8%   
Avg Mkt Cap Rs m227,89719,011 1,198.8%   
No. of employees `00014.71.5 952.1%   
Total wages/salary Rs m11,3531,696 669.2%   
Avg. sales/employee Rs Th4,083.07,150.0 57.1%   
Avg. wages/employee Rs Th772.31,098.7 70.3%   
Avg. net profit/employee Rs Th461.3608.2 75.8%   
INCOME DATA
Net Sales Rs m60,02111,040 543.7%  
Other income Rs m2,988240 1,246.7%   
Total revenues Rs m63,00911,279 558.6%   
Gross profit Rs m13,4931,376 980.4%  
Depreciation Rs m4,086264 1,547.7%   
Interest Rs m3,0850-   
Profit before tax Rs m9,3101,352 688.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0170 0.0%   
Tax Rs m2,529583 433.9%   
Profit after tax Rs m6,781939 722.1%  
Gross profit margin %22.512.5 180.3%  
Effective tax rate %27.243.1 63.0%   
Net profit margin %11.38.5 132.8%  
BALANCE SHEET DATA
Current assets Rs m52,6237,523 699.5%   
Current liabilities Rs m52,0222,253 2,309.4%   
Net working cap to sales %1.047.7 2.1%  
Current ratio x1.03.3 30.3%  
Inventory Days Days12052 229.3%  
Debtors Days Days7641 188.0%  
Net fixed assets Rs m85,0161,240 6,857.8%   
Share capital Rs m846166 509.8%   
"Free" reserves Rs m45,3767,167 633.2%   
Net worth Rs m46,2227,333 630.4%   
Long term debt Rs m41,1150-   
Total assets Rs m142,4329,912 1,436.9%  
Interest coverage x4.0NM-  
Debt to equity ratio x0.90-  
Sales to assets ratio x0.41.1 37.8%   
Return on assets %6.99.5 73.1%  
Return on equity %14.712.8 114.6%  
Return on capital %14.220.8 68.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m14,5801,015 1,437.0%   
Fx outflow Rs m3,6003,043 118.3%   
Net fx Rs m10,980-2,028 -541.4%   
CASH FLOW
From Operations Rs m8,942537 1,666.4%  
From Investments Rs m-47,070-476 9,882.3%  
From Financial Activity Rs m34,174-220 -15,547.7%  
Net Cashflow Rs m-3,655-160 2,291.5%  

Share Holding

Indian Promoters % 71.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 7.0 18.2 38.6%  
FIIs % 12.6 1.0 1,260.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 29.1 30.2%  
Shareholders   26,511 28,591 92.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  WYETH LTD  ABBOTT INDIA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 142 Points Higher; Metal and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended the day on a positive note. Gains were largely seen in the metal sector and healthcare sector.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Feb 21, 2019 03:35 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS